T2D is typically managed through a combination of lifestyle modifications—such as dietary changes, increased PA, and weight loss—and pharmacological interventions, including oral hypoglycaemic agents, subcutaneous medications, and, in some cases, insulin therapy (7). This evidence concerns the gene INS and type 2 diabetes mellitus.